Media Mentions
There are 80 results matching your search criteria
Clear all filters
Company Updates
Owlstone Medical Appoints Mark Capone to Board of Directors
Breath Biopsy
Owlstone Medical Closes $58 Million USD (c. £42 Million GBP) Oversubscribed Financing Round to Continue to Advance Breath Biopsy
COVID-19
Owlstone Medical Publishes Data on the Use of Face Mask Filters to Capture Viral Particles for SARS-CoV-2 Detection
Breath Biopsy
Owlstone Medical Launches Breath Testing for Digestive Health in Collaboration with Functional Gut Diagnostics and Functional Gut Clinic
Breath Biopsy
Owlstone Medical Introduces Breath Biopsy Panel for Respiratory Diseases
Company Updates
Owlstone Medical Expands U.S. Operations and Establishes Permanent U.S. Office
Breath Biopsy
Owlstone Medical Announces Key Study Results on use of Breath Biopsy for Improved Detection of Liver Disease including NASH and NAFLD
Breath Biopsy
DRAGON: A new international project funded by IMI and supported through the European Commission’s Horizon 2020 Framework Programme for Research and Innovation to develop a diagnostics tool combatting coronavirus infections.
Company Updates
Owlstone Medical Appoints Neil Tween as Chief Financial Officer
Company Updates
Owlstone Medical named as one of FierceMedTech’s “Fierce 15” companies of 2019
Breath Biopsy
Owlstone Medical to Join EU-Funded EPHOR Consortium to Advance Occupational Health Science in Order to Reduce Disease Burden from Workplace Exposure
